CASIA OpenIR  > 中国科学院分子影像重点实验室
Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma
Zhou, Hongyu1,2,4; Mao, Haixia3; Dong, Di2,4; Fang, Mengjie2,4; Gu, Dongsheng2,4; Liu, Xueling3; Xu, Min3; Yang, Shudong5; Zou, Jian6; Yin, Ruohan7; Zheng, Hairong1,4; Tian, Jie2,4,8,9; Pan, Changjie7; Fang, Xiangming3; Zhou, Hongyu10,11,13; Mao, Haixia12; Dong, Di11,13; Fang, Mengjie11,13; Gu, Dongsheng11,13; Liu, Xueling12; Xu, Min12; Yang, Shudong14; Zou, Jian15; Yin, Ruohan16; Zheng, Hairong10,13; Tian, Jie11,13,17,18; Pan, Changjie16; Fang, Xiangming12
发表期刊ANNALS OF SURGICAL ONCOLOGY
ISSN1068-9265
2020-05-18
卷号27期号:10页码:4057–4065
摘要

Background and Purpose Nuclear grades of clear cell renal cell carcinoma (ccRCC) are usually confirmed by invasive methods. Radiomics is a quantitative tool that uses non-invasive medical imaging for tumor diagnosis and prognosis. In this study, a radiomics approach was proposed to analyze the association between preoperative computed tomography (CT) images and nuclear grades of ccRCC. Methods Our dataset included 320 ccRCC patients from two centers and was divided into a training set (n = 124), an internal test set (n = 123), and an external test set (n = 73). A radiomic feature set was extracted from unenhanced, corticomedullary phase, and nephrographic phase CT images. The maximizing independent classification information criteria function and recursive feature elimination with cross-validation were used to select effective features. Random forests were used to build a final model for predicting nuclear grades, and area under the receiver operating characteristic curve (AUC) was used to evaluate the performance of radiomic features and models. Results The radiomic features from the three CT phases could effectively distinguished the four nuclear grades. A combined model, merging radiomic features and clinical characteristics, obtained good predictive performances in the internal test set (AUC 0.77, 0.75, 0.79, and 0.85 for the four grades, respectively), and performance was further confirmed in the external test set, with AUCs of 0.75, 0.68, and 0.73 (no fourth-level data). Conclusion The combination of CT radiomic features and clinical characteristics could discriminate the nuclear grades in ccRCC, which may help in assisting treatment decision making.

关键词Clear Cell Renal Cell Carcinoma
DOI10.1245/s10434-020-08255-6
关键词[WOS]CLASSIFICATION ; DIAGNOSIS ; MODEL
收录类别SCI
语种英语
资助项目National Key R&D Program of China[2017YFC1308700] ; National Key R&D Program of China[2017YFA0205200] ; National Key R&D Program of China[2017YFC1309100] ; National Key R&D Program of China[2016YFC0103803] ; National Key R&D Program of China[2016YFC0103001] ; National Natural Science Foundation of China[91959130] ; National Natural Science Foundation of China[81971776] ; National Natural Science Foundation of China[81771924] ; National Natural Science Foundation of China[812716298] ; National Natural Science Foundation of China[81271629] ; National Natural Science Foundation of China[81227901] ; Beijing Natural Science Foundation[L182061] ; Wuxi Medical Innovation Team Program[CXTD002] ; Bureau of International Cooperation of Chinese Academy of Sciences[173211KYSB20160053] ; Youth Innovation Promotion Association CAS[2017175]
项目资助者National Key R&D Program of China ; National Natural Science Foundation of China ; Beijing Natural Science Foundation ; Wuxi Medical Innovation Team Program ; Bureau of International Cooperation of Chinese Academy of Sciences ; Youth Innovation Promotion Association CAS
WOS研究方向Oncology ; Surgery
WOS类目Oncology ; Surgery
WOS记录号WOS:000533809900002
出版者SPRINGER
七大方向——子方向分类医学影像处理与分析
引用统计
被引频次:13[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.ia.ac.cn/handle/173211/39457
专题中国科学院分子影像重点实验室
通讯作者Zheng, Hairong; Zheng, Hairong
作者单位1.Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China
2.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing, Peoples R China
3.Nanjing Med Univ, Wuxi Peoples Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China
4.Univ Chinese Acad Sci, Beijing, Peoples R China
5.Nanjing Med Univ, Wuxi Peoples Hosp, Dept Pathol, Wuxi, Jiangsu, Peoples R China
6.Nanjing Med Univ, Wuxi Peoples Hosp, Ctr Clin Res, Wuxi, Jiangsu, Peoples R China
7.Nanjing Med Univ, Dept Radiol, Changzhou Peoples Hosp 2, Changzhou, Jiangsu, Peoples R China
8.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Me, Sch Med, Beijing, Peoples R China
9.Xidian Univ, Engn Res Ctr Mol & Neuro Imaging, Sch Life Sci & Technol, Minist Educ, Xian, Shaanxi, Peoples R China
10.Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China
11.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing, Peoples R China
12.Nanjing Med Univ, Wuxi Peoples Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China
13.Univ Chinese Acad Sci, Beijing, Peoples R China
14.Nanjing Med Univ, Wuxi Peoples Hosp, Dept Pathol, Wuxi, Jiangsu, Peoples R China
15.Nanjing Med Univ, Wuxi Peoples Hosp, Ctr Clin Res, Wuxi, Jiangsu, Peoples R China
16.Nanjing Med Univ, Dept Radiol, Changzhou Peoples Hosp 2, Changzhou, Jiangsu, Peoples R China
17.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Me, Sch Med, Beijing, Peoples R China
18.Xidian Univ, Engn Res Ctr Mol & Neuro Imaging, Sch Life Sci & Technol, Minist Educ, Xian, Shaanxi, Peoples R China
第一作者单位中国科学院自动化研究所
推荐引用方式
GB/T 7714
Zhou, Hongyu,Mao, Haixia,Dong, Di,et al. Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma[J]. ANNALS OF SURGICAL ONCOLOGY,2020,27(10):4057–4065.
APA Zhou, Hongyu.,Mao, Haixia.,Dong, Di.,Fang, Mengjie.,Gu, Dongsheng.,...&Fang, Xiangming.(2020).Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma.ANNALS OF SURGICAL ONCOLOGY,27(10),4057–4065.
MLA Zhou, Hongyu,et al."Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma".ANNALS OF SURGICAL ONCOLOGY 27.10(2020):4057–4065.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2020_ASO_Zhouhongyu_(1325KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhou, Hongyu]的文章
[Mao, Haixia]的文章
[Dong, Di]的文章
百度学术
百度学术中相似的文章
[Zhou, Hongyu]的文章
[Mao, Haixia]的文章
[Dong, Di]的文章
必应学术
必应学术中相似的文章
[Zhou, Hongyu]的文章
[Mao, Haixia]的文章
[Dong, Di]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 2020_ASO_Zhouhongyu_preview.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。